Clinical trials are imperative for testing novel cancer therapies, advancing the science of
cancer care, and determining the best treatment strategies to enhance outcomes for patients …

Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But although barriers
to trial participation have been the subject of frequent study, the rate of trial participation has …

Research conducted through clinical trials is essential for evaluating new treatment
modalities, establishing new standards of cancer care, and ultimately improving and …

BACKGROUND: Recruitment of cancer patients to clinical trials is an ongoing challenge. In
this study, we assess factors that may influence enrollment in clinical trials for cancer …

Background Barriers to cancer clinical trial participation have been the subject of frequent
study, but the rate of trial participation has not changed substantially over time. Studies often …

As more clinical trials of molecularly targeted agents evolve, the number of eligibility criteria
seems to be increasing. The importance and utility of eligibility criteria must be considered in …

Financial barriers to clinical trial enrollment are an area of active investigation. Financial
toxicity as a concept describes how high costs and financial burden can lead to …

Cancer clinical trials are critical for testing new treatments, yet less than 5% of patients with
cancer enroll in these trials. Minority groups, elderly individuals, and rural populations are …

Although clinical trial research is required for the development of improved treatment
strategies, very few cancer patients participate in these studies. The purpose of this study …

PURPOSE To discuss patient eligibility criteria in phase III cancer clinical trials in the larger
setting of the complexity of these trials, to review the various reasons for imposing restrictive …